相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
Viktorija Juric et al.
CANCER DRUG RESISTANCE (2020)
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
David J. Voce et al.
CANCER RESEARCH (2019)
Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma
Janis J. Noonan et al.
CANCERS (2019)
Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis
Vimal Pandey et al.
SCIENTIFIC REPORTS (2019)
Synthesis and anti-tumor activity of EF24 analogues as IKK beta inhibitors
Rong Jin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas
Longtao Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
Radek Jorda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1
Qin Shi et al.
CANCER BIOMARKERS (2017)
1, 25(OH)2D3-induced interaction of vitamin D receptor with p50 subunit of NF-κB suppresses the interaction between KLF5 and p50, contributing to inhibition of LPS-induced macrophage proliferation
Dong Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
Aleksei A. Stepanenko et al.
CANCER CELL INTERNATIONAL (2016)
Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide
Nassir M. Mansour et al.
CANCER RESEARCH (2015)
Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells
Baosheng Zhou et al.
MEDICAL ONCOLOGY (2015)
Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma
Andrew R. Tsen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells
Takuro Hayashi et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site
Clayton D. Crawley et al.
NUCLEIC ACIDS RESEARCH (2013)
p50 (NF-κB1) Is an Effector Protein in the Cytotoxic Response to DNA Methylation Damage
Adam M. Schmitt et al.
MOLECULAR CELL (2011)
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
Neil Johnson et al.
NATURE MEDICINE (2011)
Processing of O-6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles
Steve Quiros et al.
CELL CYCLE (2010)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo
Hua Chen et al.
BMC CANCER (2008)
Bcl-3, a multifaceted modulator of NF-κB-mediated gene transcription
Scott Palmer et al.
IMMUNOLOGIC RESEARCH (2008)
New regulators of NF-κB in inflammation
Sankar Ghosh et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inhibition of nuclear factor-κB activity by temozolomide involves O6-methylguanine-induced inhibition of p65 DNA binding
Bakhtiar Yamini et al.
CANCER RESEARCH (2007)
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway
N. D. Perkins
ONCOGENE (2006)
Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells
Dongpo Cai et al.
CANCER RESEARCH (2006)
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1
Lyubomir T. Vassilev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Signals from within:: the DNA-damage-induced NF-κB response
S Janssens et al.
CELL DEATH AND DIFFERENTIATION (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Transcriptional targeting of adenovirally delivered tumor necrosis factor α by temozolomide in experimental glioblastoma
B Yamini et al.
CANCER RESEARCH (2004)
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen et al.
CELL PROLIFERATION (2003)
分享论文
